Skip to main content
. 2021 Feb 26;13(3):306. doi: 10.3390/pharmaceutics13030306

Figure 9.

Figure 9

(A) uptake of BRB or BRB-L by K562 and K562/DOXO cells, after 2 h-incubation; (B) uptake of BRB/TAR, BRB-L/TAR, or BRB/TAR-L by K562/DOXO cells, after 2 h-incubation. RF = fluorescence ratios of sample treated and the control (empty liposome), * p < 0.05.